Environmental Impact Acquisition Corp
ENVI · Nasdaq
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC, listed on Nasdaq in January 2021.
- What it's doing now
- It agreed to buy GreenLight Biosciences Holdings, PBC, a RNA-based vaccines and therapeutics development company. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- GreenLight Biosciences Holdings, PBC — Biosciences GreenLight Biosciences aims to address some of the worlds biggest problems by delivering on the full potential of RNA for human health and agriculture.
- Industry
- Health Care — RNA-based vaccines and therapeutics development
- Deal value
- not stated in the filings we hold
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 15 January 2021
- size not on file
- Headquarters
- 29 HARTWELL AVENUE, LEXINGTON, MA, 02421
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- COONEY CHARLES L (Director)
- Listed securities
- ENVI common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
1 dated milestoneEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 15 January 2021IPOpassed
IPO size not on file
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- closedHealth Care
What GreenLight Biosciences Holdings, PBC does — read from greenlightbiosciences.com on 26 August 2026
GreenLight Biosciences develops RNA-based agricultural solutions, including insecticides and treatments for crops and bees. The company has secured regulatory authorizations and launched products such as Norroa for Varroa mites and an RNA-based insecticide receiving Belgian Emergency Use Authorization in the EU.
AgricultureCrop ProtectionBee HealthDeal structureSEC-primary — BCA 8-K / S-4 / DEFM14A- Min-cash condition
- $275M
stated in:0001193125-21-301564
The score
deterministic, from filed fieldsENVI is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 295 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
Environmental Impact Acquisition Corp was a self-described blank check company that listed its common stock on the Nasdaq Stock Market under the ticker ENVI. The company priced its initial public offering on January 15, 2021, under SEC file number 333-251593. Its SEC CIK is 0001822691, and it operated under SEC SIC industry code 2836 (Biological Products, (No Diagnostic Substances)). The vehicle completed a business combination and no longer files, with its closed status established by a Form 25 filed on July 24, 2023. EDGAR now files this CIK as GreenLight Biosciences Holdings, PBC.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
The consideration basis is again an implied GreenLight equity value of $1.2 billion, with GreenLight capital stock exchanged for ENVI Class A common stock and options and warrants converted into comparable ENVI instruments, and the prospectus again covers 120,000,000 shares as a maximum. Two days separate this amendment from the previous one and the read portion is identical apart from the amendment number and the date, so what changed lies outside it. Nothing substantive is recorded here on the strength of the difference in numbering alone.
The consideration basis restated here is an implied GreenLight equity value of $1.2 billion, with GreenLight capital stock exchanged for ENVI Class A common stock and GreenLight options and warrants converted into comparable ENVI instruments. The prospectus covers 120,000,000 shares as a maximum rather than an expectation. What this amendment altered is not visible in the portion of the document read: the cover, the transaction description and the covered share count match the neighbouring amendment word for word. No substantive change is recorded, rather than one being inferred.
The exchange is fixed to a valuation rather than to a share count: each outstanding share of GreenLight capital stock is exchanged for ENVI Class A Common Stock, and GreenLight options and warrants, vested or unvested, convert into comparable ENVI instruments, in each case based on an implied GreenLight equity value of $1.2 billion. The 120,000,000 shares the prospectus covers are described as the maximum issuable to GreenLight's stockholders, optionholders and warrantholders, so the figure is a ceiling and not the consideration.
Consideration is set by an implied GreenLight equity value of $1.2 billion rather than by a fixed share count: GreenLight capital stock is exchanged for ENVI Class A common stock and GreenLight options and warrants convert into comparable ENVI instruments on that basis. The prospectus covers 120,000,000 shares, the maximum issuable to GreenLight holders rather than the expected number. ENVI's own Class A and Class B shares all become New GreenLight common stock. The proposed Nasdaq symbol is left blank, and conditional Nasdaq approval of the listing application is a closing condition.
The prospectus cover carries no share count at all, so a holder cannot size the dilution from this version — the figure that matters is simply absent where comparable filings print it. The document is marked preliminary and subject to completion, so the securities may not be sold until the registration statement is effective, and no meeting date is stated. ENVI's stockholders are asked to consider and vote upon the Business Combination and the other proposals described in the proxy statement/prospectus.
The 120,000,000 is stated on the assumption that every outstanding option and warrant to acquire GreenLight common stock is exercised before the closing, so it is a fully diluted ceiling rather than a count of shares actually delivered, and holders who do not exercise reduce it. The fee table carries no separate line for an earnout or for assumed equity awards, so 120,000,000 is the whole registered amount. The $9.84 is a market average used only to compute the fee.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
Show the other 10 filings
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
No sponsor entity is named in the filings parsed for this SPAC so far.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1280 tracked SPACs (24%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
from 424B3 0000950170-23-006832
Trading & liquidity
Company profile
Directors & officers
- COONEY CHARLES LDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
48 filers with a stake on file (largest 20 shown) · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- Fall Line Endurance Fund, LPwith 3 other reporting persons on the same schedule7.6% · SC 13D/AJun 16, 2023 stale
- Fall Line Endurance GP, LLC7.3% · SC 13DFeb 25, 2022 stale
- Cormorant Global Healthcare Master Fund, LPwith 5 other reporting persons on the same schedule6.1% · SC 13DJun 8, 2023 stale
- FIR TREE CAPITAL MANAGEMENT LP5.2% · SC 13GFeb 14, 2022 stale
- Gonzalez May Carlos Alfredowith 3 other reporting persons on the same schedule4.2% · SC 13DJun 8, 2023 stale
- Prelude Ventures LLCwith 1 other reporting person on the same schedule2.1% · SC 13DJun 8, 2023 stale
- Tao Capital Management LPwith 2 other reporting persons on the same schedule1.8% · SC 13DJun 8, 2023 stale
- Lewis & Clark Ventures I, LPwith 1 other reporting person on the same schedule1.2% · SC 13DJun 8, 2023 stale
- HIGHBRIDGE CAPITAL MANAGEMENT LLC1.1% · SC 13G/AJan 30, 2023 stale
- CG Investments Inc. VI1.0% · SC 13DJun 12, 2023 stale
- RiverRoad Capital Partners, LLCwith 1 other reporting person on the same schedule1.0% · SC 13DJun 8, 2023 stale
- Cummings Foundation, Inc.0.8% · SC 13DJun 13, 2023 stale
- Serum Life Sciences Ltd0.7% · SC 13DJun 8, 2023 stale
- Series Greenlight, a separate series of BlueIO Growth LLCwith 3 other reporting persons on the same schedule0.4% · SC 13DJun 7, 2023 stale
- New Stuff, LLCwith 1 other reporting person on the same schedule0.3% · SC 13DJun 8, 2023 stale
- RPB VENTURES LLCwith 2 other reporting persons on the same schedule0.2% · SC 13DJul 25, 2023 stale
- RUETTGERS MICHAEL C0.1% · SC 13DJun 8, 2023 stale
- Sagar Rosemary0.1% · SC 13DJun 8, 2023 stale
- Brewster David B0.1% · SC 13DJun 13, 2023 stale
- Furneaux Carol0.1% · SC 13DJun 14, 2023 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
35 full SEC filing texts archived — searchable, never lost.
- Vault note — ENVI (Environmental Impact Acquisition Corp)
vault-note · /vault/tickers/ENVI
- Vault deal note — GreenLight Biosciences Holdings, PBC (ENVI)
vault-note · /vault/deals/greenlight-biosciences-holdings-pbc
- GreenLight Biosciences - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
news · tracxn.com
- GreenLight Biosciences Enters into Definitive Merger
news · globenewswire.com
- GreenLight Biosciences 2026
company-site · greenlightbiosciences.com
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail3 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from EDGAR's QUARTERLY FORM INDEX, walked without any SIC filter. The SIC 6770 census could not reach this registrant: EDGAR reassigns a shell's SIC the day it stops being one, and this CIK now files under 2836 (Biological Products, (No Diagnostic Substances)). The screen found it by filing SHAPE instead — S-1 2020-12-21 → 8-A12B 2021-01-13 → 424B4 2021-01-15 — which nothing rewrites. Admission rule: src/lib/universe-admit.ts. SIC 2836 + self-described blank check in 424B4 0001213900-21-002606; 424B 0001213900-21-002606 priced 2021-01-15 under S-1 0001213900-20-043891 (file 333-251593, an offering for cash); common ticker ENVI off 10-Q 0001213900-21-058266 (2021-11-12); lifecycle EXITED. The pricing prospectus was filed under SEC file number 333-251593, which belongs to S-1 0001213900-20-043891 (2020-12-21) — a registration of shares sold for CASH, which is what makes it an IPO rather than merger consideration. Blank-check status from the registrant's own first-person sentence in that prospectus (EDGAR full-text search, 424B4 2021-01-15). Ending PROVEN, not inferred: CLOSED per Form 25 0001354457-23-000521 (2023-07-24) — Form 25 filed under 17 CFR 240.12d2-2(a)(3) — the rule for securities that "have come to evidence other securities in substitution therefor", i.e. the shares became the successor's (class: Common Stock & Warrant). EDGAR now files this CIK as "GreenLight Biosciences Holdings, PBC" — the SPAC's own name is kept here and the successor is the target. ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
[CLOSED-RENAME] EDGAR CIK 0001822691 records "Environmental Impact Acquisition Corp" ending 2022-02-03; the registrant continues as "GreenLight Biosciences Holdings, PBC". The rename is the SEC's own record of what the vehicle became, keyed by CIK. Closed 2022-02-03. No deal value is set — a rename says what was acquired, never for how much. No date column is set: Deal has announcedAt, voteDate and expectedCloseAt and nowhere to record an actual close, so the SEC's date is kept here until that column exists. [DEAL-STRUCTURE-MINED] minCashM=275 from primary filings (0001193125-21-301564).
OTHER -> BIOTECH, on S-4/A 0001193125-22-007945: "ENVI sought to acquire one or more companies that: have an enterprise value between $750 million and $2 billion; offer innovative and unique products, services "